Matches in Wikidata for { <http://www.wikidata.org/entity/Q66079116> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q66079116 description "clinical trial" @default.
- Q66079116 description "ensayu clínicu" @default.
- Q66079116 description "клінічне випробування" @default.
- Q66079116 name "Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)" @default.
- Q66079116 type Item @default.
- Q66079116 label "Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)" @default.
- Q66079116 prefLabel "Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)" @default.
- Q66079116 P1050 Q66079116-99A4B54E-2991-45BE-81ED-1E3C6DD98D45 @default.
- Q66079116 P1132 Q66079116-D57CEB23-A2B9-4174-922E-94745C08CE70 @default.
- Q66079116 P1476 Q66079116-3DCD62E9-FAED-44E3-AD23-0CEBC1A7CF0F @default.
- Q66079116 P17 Q66079116-F9B01458-A7D6-4149-A683-B615717E99DE @default.
- Q66079116 P1813 Q66079116-7D2503EB-A5A2-4168-BC34-5BAAD6DF6323 @default.
- Q66079116 P2899 Q66079116-3C7911D9-9004-4A3A-A48F-4E6000440CFE @default.
- Q66079116 P3098 Q66079116-C0BD96C0-A9A2-4318-AC7B-83CC0965F88E @default.
- Q66079116 P31 Q66079116-27575A16-C0CC-44D1-8C7B-C1A99846D89A @default.
- Q66079116 P4135 Q66079116-6BE981F4-CB07-4392-A339-5A45406F2205 @default.
- Q66079116 P4844 Q66079116-2B3133E9-B81F-4756-AD7A-682316A30D6E @default.
- Q66079116 P580 Q66079116-D4AEC48B-F6C0-4B57-954A-85BCAA795D6A @default.
- Q66079116 P582 Q66079116-C3990966-8DCE-43AC-A9F0-B700508F1CCA @default.
- Q66079116 P6099 Q66079116-29525EE3-6D80-4843-97CF-5B2980DE4E29 @default.
- Q66079116 P6153 Q66079116-8CA2A2A3-6E32-4123-94BF-719C6B841526 @default.
- Q66079116 P6153 Q66079116-C47B8B4A-51E4-45EE-BD1D-980565882E0D @default.
- Q66079116 P6153 Q66079116-C639DFBA-0580-41E5-A7EA-4E6DC98BC48B @default.
- Q66079116 P8363 Q66079116-C25E6321-8E49-492E-92BF-9B120259015F @default.
- Q66079116 P1050 Q5445 @default.
- Q66079116 P1132 "+264" @default.
- Q66079116 P1476 "A Prospective, Randomized, Double Blind, Parallel Group Study to Evaluate a 1:1 Dose Conversion From EPREX to EPIAO in Term of Clinical Efficacy and Safety in Subjects With End-Stage Renal Disease on Haemodialysis" @default.
- Q66079116 P17 Q869 @default.
- Q66079116 P1813 "BEAT_002" @default.
- Q66079116 P2899 "+18" @default.
- Q66079116 P3098 "NCT02947438" @default.
- Q66079116 P31 Q30612 @default.
- Q66079116 P4135 "+75" @default.
- Q66079116 P4844 Q5383794 @default.
- Q66079116 P580 "2015-12-01T00:00:00Z" @default.
- Q66079116 P582 "2019-11-01T00:00:00Z" @default.
- Q66079116 P6099 Q42824827 @default.
- Q66079116 P6153 Q13026856 @default.
- Q66079116 P6153 Q13026863 @default.
- Q66079116 P6153 Q4385323 @default.
- Q66079116 P8363 Q78089383 @default.